The pathophysiology of respiratory impairment in pediatric neuromuscular diseases

Howard B Panitch1

  • 1Division of Pulmonary Medicine, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. panitch@email.chop.edu

Pediatrics
|May 8, 2009
PubMed

Insights

Pediatric neuromuscular disorders can cause respiratory impairment. Understanding the pathophysiology is key for effective pulmonary management in children with these conditions.

Area of Science:

  • Pediatric Pulmonology
  • Neuromuscular Disorders
  • Respiratory Pathophysiology

Background:

  • Neuromuscular disorders significantly impact respiratory function in children.
  • Effective pulmonary management strategies are crucial for this patient population.

Purpose of the Study:

  • To summarize the pathophysiology of respiratory impairment in pediatric neuromuscular disorders.
  • To inform pulmonary management approaches for affected children.

Main Methods:

  • Presentation at the 30th annual Carrell-Krusen Neuromuscular Symposium.
  • Focused on the pathophysiology of respiratory impairment.

Main Results:

  • Detailed the mechanisms of respiratory compromise in pediatric neuromuscular diseases.
  • Highlighted the link between neuromuscular dysfunction and breathing difficulties.

Conclusions:

  • A thorough understanding of pathophysiology is essential for optimizing respiratory care.
  • This knowledge aids in developing targeted interventions for pediatric patients.

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...